Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination

Pediatrics

Volumn 120, Issue 4, 2007, Pages

  Sterling, Timothy R ^a,h   Martire, Terezinha ^b,c   De Almeida, Alexandre Silva ^b   Ding, Li ^d   Greenberg, David E ^d   Moreira, Lorena Alves ^b   Elloumi, Houda ^d   Torres, Angelica P V ^b   Sant'Anna, Clemax Couto ^b   Calazans, Eliane ^e   Paraguassu, Geraldo ^f,g   Gebretsadik, Tebeb ^a   Shintani, Ayumi ^a   Miller, Kathleen ^a   Kritski, Afranio ^b   Silva, Jose Roberto Lapa ^b   Holland, Steven M ^d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e Department of Pediatrics   (Brazil)

^f Hospital Sao Goncalo   (Brazil)

^g Hosp Munic Jesus   (Brazil)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BCG vaccine; M tuberculosis; MCP 1; Miliary tuberculosis; Tuberculosis; Tuberculosis meningitis

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

AGE DISTRIBUTION; ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; BODY MASS; BRAZIL; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOSTIMULATION; KRUSKAL WALLIS TEST; LUNG TUBERCULOSIS; MALE; MILIARY TUBERCULOSIS; MULTIVARIATE ANALYSIS OF VARIANCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOUS MENINGITIS;

BCG VACCINE; BRAZIL; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES; TUBERCULIN; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, PULMONARY;

EID: 35148870024     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-3150     Document Type: Article

References (38)

1. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99:131-138
2. Gonzalez OY, Adams G, Teeter LD, Bui TT, Musser JM, Graviss EA. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis. 2003;7:1178-1185
3. Ong A, Creasman J, Hopewell PC, et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis. 2004;38:25-31
4. Yang Z, Kong Y, Wilson F, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38:199-205
5. Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 counts in patients with human immunodeficiency infection. Am Rev Respir Dis. 1993;148:1292-1297
6. Wallgren A. The time-table of tuberculosis. Tubercle. 1948;29:245-251
7. Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis. 1990;141:347-351
8. Lewinsohn DA, Gennaro ML, Scholvinck L, Lewinsohn DM. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis. 2004;8:658-674
9. van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev. 2002;15:294-309
10. Orme I. Adaptive immunity to mycobacteria. Curr Opin Microbiol. 2004;7:58-61
11. Lincoln EM, Sordillo SVR, Davies PA. Tuberculous meningitis in children. J Pediatr. 1960;57:807-823
12. Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA. 1979;241:264-268
13. Hussey G, Chisolm T, Kibel M. Miliary tuberculosis in children: a review of 94 cases. Pediatr Infect Dis J. 1991;10:832-836
14. Sterling TR, Dorman SE, Chaisson RE, et al. HIV-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses. Clin Infect Dis. 2001;33:976-982
15. Antas PRZ, Ding L, Hackman J, et al. Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis. J Allerg Clin Immunol. 2006;117:916-923
16. Feja K, Saiman L. Tuberculosis in children. Clin Chest Med. 2005;26:295-312, vii
17. Alcais A, Fieschi C, Abel L, Casanova JL. Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med. 2005;202:1617-1621
18. Starke JR. Tuberculosis in children. Semin Respir Crit Care Med. 2004;25:353-364
19. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993;22:1154-1158
20. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analysis of the published literature. Pediatrics. 1995;96:29-35
21. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA. 1994;271:698-702
22. Comstock GW. Field trials of tuberculosis vaccines: how could we have done them better. Control Clin Trials. 1994;15:247-276
23. ten Dam HG, Pio A. Pathogenesis of tuberculosis and effectiveness of BCG vaccination. Tubercle. 1982;63:225-233
24. Aronson NE, Santosham M, Comstock GW, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. JAMA. 2004;291:2086-2091
25. Sutherland I, Lindgren I. The protective effect of BCG vaccination as indicated by autopsy studies. Tubercle. 1979;60:225-231
26. Soysal A, Millington KA, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet. 2005;366:1443-1451
27. Hasan Z, Zaidi I, Jamil B, Khan MA, Kanji A, Hussain R. Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol. 2005;6:14
28. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med. 2005;202:1649-1658
29. Lopez-Maderuelo D, Arnalich F, Serantes R, et al. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med. 2003;167:970-975
30. Cooley WW, Lohnes PR. Multivariate Data Analysis. New York, NY: John Wiley & Sons; 1971
31. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med. 1994;330:1703-1709
32. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994;330:1710-1716
33. Bishai WR, Graham NMH, Harrington S, et al. Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA. 1998;280:1679-1684
34. Jasmer RM, Hahn JA, Small PM, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med. 1999;130:971-978
35. Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev. 2005;203:38-47
36. Simmons CP, Thwaites GE, Quyen NT, et al. Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome. J Immunol. 2006;176:2007-2014
37. Simmons CP, Thwaites GE, Quyen NT, et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J Immunol. 2005;175:579-590
38. Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis. 2005;5:415-430